Gsk Share Discussion Threads

[alphorn] 04/7/2017 10:23

The EMA moving out was never good news.

Reality is slowly dawning:

"The government has moved to dampen fears in the pharmaceutical and life sciences industry that Brexit will mean patients and the NHS will wait longer and pay more for drugs and treatment.

The health secretary, Jeremy Hunt, and the business secretary, Greg Clark, have said they want to continue to “work closely” with the European Medicines Agency, the EU regulatory authority currently based in London.

They have offered to bridge the drug licensing gap that will open when the UK drops its membership of the EMA in the wake of Brexit.

“Our door will always be open to a deep and special relationship with the EU, which remains the best way to promote improved patient outcomes both in Europe and globally,” they say in a letter to the Financial Times.

This is a significant softening of position for Hunt, who told MPs in January that he did not expect the UK to continue as a member once it left the EU, a move that was branded by Labour as “reckless̶1;." (Guardian)

[toffeeman] 03/7/2017 12:56

1560 is the target based on the support line from Dec 2016

[ny boy] 03/7/2017 12:41

Reckon 1590p will be visited

[philanderer] 03/7/2017 11:01

Frontier IP portfolio company collaboration with GSK

[philanderer] 03/7/2017 08:20

Quiet day today and tuesday.

US markets just the half day today and closed all day tomorrow for Independence Day

[tradermichael] 01/7/2017 08:26

m_k_hubbert - yes, and for my trades at £150K, I factor in a 7.5p increase in GSK share price is required for my costs to break even. ..... ;0)

[philanderer] 30/6/2017 21:21

'Big pharma cash and hospitality to doctors rises as one in three refuses to reveal earnings'


......The NHS has called on pharmaceutical companies to refuse to pay practitioners unless they agree to publicly disclose their earnings.

But only a small handful of companies, most notably Glaxo Smith Kline, have complied.

[philanderer] 30/6/2017 18:10

'These Two Biotech Stocks Could Move On Near Term Vaccine Catalysts'

[philanderer] 30/6/2017 14:26

'Vulnerable Drugmakers Can't Shrug Off the FDA'

[m_k_hubbert] 30/6/2017 14:14

Broker's commission (assuming online dealing) isn't really a factor for sizeable trades. Transfer stamp @0.5% however puts a dampener on trading too frequently. While not in TM's league when I bought back into GSK yesterday the transfer stamp was >20x broker's commission, ouch!

[tradermichael] 30/6/2017 12:49

But it is a question of scale - the percentages are the same (discounting for dealing costs).

Anyway (for the 'record') its £400K since 28 June ..... ;0)

[toffeeman] 30/6/2017 12:26

I am happy to accept TM(1's) statement - I just find it hard to get my head round an individual ADVFNer investing £250,000 in one stock in two days. It must be atypical, or am I just a member of an extremely long tail :)

TM(2)

[tradermichael] 30/6/2017 10:45

Solomon - thanks - you have it right there! ...... ;0)

[tradermichael] 30/6/2017 10:43

Toffeeman - you're incorrect on all 3 counts (and I never do CFD's either).

GSK is a winner and 2050p is on the cards. I am a long term holder. All the support I need comes from the dividends, but I do like to trade in/out/in whenever it gets to the kind of volatility that we are seeing at the moment ..... good luck all, this morning was the time to buy. August brings another qualifying dividend ..... ;0)

[solomon] 30/6/2017 10:42

TM has a good record. He IS too heavy in GSK but he knows how to play it (until he gets it wrong). Above all he is honest about his trading, which is exemplary. All IMHO.

[alphorn] 30/6/2017 10:25

As Girolami (ex Glaxo boss) said about Zantac if you have all your eggs in one basket - make sure that it is a good basket.

[grahamite2] 30/6/2017 10:12

or 4. CFDs on margin

[toffeeman] 30/6/2017 10:10

quarter of a mill means one of three things TM

1. You have a portfolio worth over £3m
2. You have too much invested in GSK
3. You are a BSer

I'll go with 1 :)

TM (2)

[tradermichael] 30/6/2017 10:00

IN yesterday, 8328 shares @ 1660.50
IN today, 7065 shares @ 1632.00

[grahamite2] 30/6/2017 09:38

Blimey! Well I'm most grateful to those here who said to sell at 1710 or thereabouts.

[philanderer] 30/6/2017 09:34

30th june Deutsche hold tp 1720p
30th june JP Morgan Caz neutral tp 1750p

reiterations

[ny boy] 30/6/2017 07:25

May see a test of 1590p now

[philanderer] 28/6/2017 20:51

Telegraph market report:


Pharmaceutical companies GlaxoSmithKline and AstraZenaca were among the worst performers on the FTSE 100 yesterday, being pulled down by US president Donald Trump’s stumbling health care reform plans. The sector was the worst performing on the blue chip index, which was weighed down by the pound gaining ground after Bank of England governor Mark Carney’s speech at the ECB Forum. GSK fell 34p, or 2pc, to £16.64 and AstraZenaca closed 107p down to £52.40.

“It’s the ongoing uncertainty, that’s what the market is not really liking,” said Dr Julie Simmonds, director of equity research at Panmure Gordon. She added: “They’re all exposed to the US market, a larger proportion of their revenue will come from there than anywhere else. The US health care stocks were coming off quite severely and that then has an effect on the European ones.

“The proposed changes are quite significant but we don’t know what is going to pass and what isn’t. It’s going to come back because it’s one of his leading pieces of legislation but when and how causes the uncertainty.”